RIVERSIDE, CA--(Marketwire - August 23, 2012) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary medical products for the growing $4 billion respiratory markets, announced today that the company has received a purchase order for 7,760 Oxyview® units on August 10, 2012. The National Distributor has agreed to provide all of the E-Commerce and Business-2-Business services for product orders and sales.
The Ingen Oxyview® and Smart Nasal Cannula products will be stocked in our distributor's warehouse inventory and available on their distributor websites on or about the first or second week of September. At that point, Ingen will launch a new website that links the product pages on the Ingen website to their product landing sales pages on our distributor's website. The change from the old direct sales program to the new national distribution program enhances sales and customer service for patients and commercial accounts.
"Our new National Distributor is a leading distributor of home medical and infusion products which promote recovery and active lifestyles for people with disabilities and those who require non-acute medical care. We are working very closely in order to successfully sell our proprietary Oxyview® and Smart Nasal Cannula to the respiratory market. Our new website will launch in September, and all purchases will be routed to our new National Distributor through Electronic Data Interchange (EDI)," stated Gary B. Tilden, Chairman of Ingen.
"Now that we have our national distribution program in place, we will focus our marketing efforts on the government contract we have in place with the Government Services Administration (GSA). This will allow us to distribute future orders from the Department of Defense and VA Hospitals throughout the U.S. and abroad."
FOR MORE UPDATED INFORMATION USE THE FOLLOWING LINK: www.otcfn.com/ignt/
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.